| RS1554613998 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS1554614022 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS1554614024 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS1554614038 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS1554614131 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS1554614157 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS1554614402 |
CNGB3
|
Health Risk |
Likely pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS1554614423 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS1554614648 |
HSPB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronopathy, distal hereditary motor |
| RS1554614680 |
HSPB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2F, Charcot-Marie-Tooth disease axonal type 2F |
| RS1554614771 |
TMEM67
|
Health Risk |
Pathogenic |
— |
| RS1554614893 |
CSPP1
|
Health Risk |
Pathogenic |
Joubert syndrome 21, Joubert syndrome 21 |
| RS1554615511 |
EYA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Branchiootorenal syndrome 1, Melnick-Fraser syndrome |
| RS1554615516 |
TMEM67
|
Health Risk |
Pathogenic |
COACH syndrome 1, COACH syndrome 1 |
| RS1554615536 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS1554616627 |
YWHAG
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 56 |
| RS1554616628 |
YWHAG
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 56 |
| RS1554616630 |
YWHAG
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 56 |
| RS1554617011 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal dysplasia type I, Trichorhinophalangeal syndrome |
| RS1554617573 |
TRPS1
|
Health Risk |
Likely pathogenic |
Trichorhinophalangeal dysplasia type I, Trichorhinophalangeal dysplasia type I |
| RS1554617580 |
TRPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Trichorhinophalangeal dysplasia type I, Trichorhinophalangeal syndrome |
| RS1554617582 |
TRPS1
|
Health Risk |
Pathogenic |
Langer-Giedion syndrome, Inborn genetic diseases |
| RS1554618404 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS1554618413 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS1554618417 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS1554618420 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS1554619292 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia |
| RS1554619303 |
CNGB3
|
Health Risk |
Likely pathogenic |
Achromatopsia 3, Achromatopsia |
| RS1554619354 |
SMARCA2
|
Health Risk |
Likely pathogenic |
— |
| RS1554619498 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS1554619500 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS1554619509 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS1554619513 |
CNGB3
|
Health Risk |
Likely pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS1554619514 |
CNGB3
|
Health Risk |
Likely pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS1554621211 |
VLDLR
|
Health Risk |
Pathogenic |
— |
| RS1554622049 |
KCNQ3
|
Health Risk |
Conflicting classifications of pathogenicity |
Benign neonatal seizures, Benign neonatal seizures |
| RS1554622608 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554622622 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554622647 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554622718 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554622736 |
SACK1H
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, hypocalcification type |
| RS1554623111 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554623112 |
SMARCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Nicolaides-Baraitser syndrome, Intellectual disability |
| RS1554623490 |
SACK1H
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, hypocalcification type |
| RS1554623885 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554624095 |
SMARCA2
|
Health Risk |
Likely pathogenic |
— |
| RS1554624100 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Nicolaides-Baraitser syndrome, Nicolaides-Baraitser syndrome |
| RS1554625334 |
ZP3
|
Health Risk |
Pathogenic |
Empty follicle syndrome, Oocyte maturation defect 3 |
| RS1554625617 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554625632 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554625693 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554625838 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554625872 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554626549 |
KCNQ3
|
Health Risk |
Pathogenic |
Self-limited epilepsy with centrotemporal spikes, Seizures |
| RS1554626829 |
SMARCA2
|
Health Risk |
Likely pathogenic |
— |
| RS1554627019 |
KCNQ3
|
Health Risk |
Pathogenic |
Benign neonatal seizures, Benign neonatal seizures |
| RS1554627025 |
KCNQ3
|
Health Risk |
Likely pathogenic |
— |
| RS1554627073 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS1554627218 |
KCNQ3
|
Health Risk |
Conflicting classifications of pathogenicity |
Benign neonatal seizures, Seizure |
| RS1554627439 |
KCNQ3
|
Health Risk |
Likely pathogenic |
Seizures, benign familial neonatal |
| RS1554628460 |
KCNV2
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1554629007 |
SMARCA2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554632235 |
TRAPPC9
|
Health Risk |
Pathogenic |
— |
| RS1554634091 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554634138 |
VPS13B
|
Health Risk |
Pathogenic |
— |
| RS1554635488 |
MAFA
|
Health Risk |
Likely pathogenic |
Islet cell adenomatosis, Islet cell adenomatosis |
| RS1554639173 |
NFIB
|
Health Risk |
Pathogenic |
Macrocephaly, Intellectual disability |
| RS1554641505 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1554641519 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1554641549 |
PUF60
|
Health Risk |
Likely pathogenic |
— |
| RS1554641737 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy 1, Glycine encephalopathy 1 |
| RS1554641887 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1554642022 |
PUF60
|
Health Risk |
Pathogenic |
8q24.3 microdeletion syndrome, 8q24.3 microdeletion syndrome |
| RS1554642294 |
GLDC
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1554642300 |
GLDC
|
Health Risk |
Likely pathogenic |
— |
| RS1554642573 |
PUF60
|
Health Risk |
Pathogenic |
8q24.3 microdeletion syndrome, 8q24.3 microdeletion syndrome |
| RS1554643099 |
PUF60
|
Health Risk |
Pathogenic/Likely pathogenic |
8q24.3 microdeletion syndrome, 8q24.3 microdeletion syndrome |
| RS1554643142 |
PUF60
|
Health Risk |
Pathogenic/Likely pathogenic |
8q24.3 microdeletion syndrome, 8q24.3 microdeletion syndrome |
| RS1554643168 |
PUF60
|
Health Risk |
Likely pathogenic |
— |
| RS1554643354 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1554643360 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1554643370 |
GLDC
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycine encephalopathy 1, Glycine encephalopathy |
| RS1554643463 |
PUF60
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554643473 |
PUF60
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, 8q24.3 microdeletion syndrome |
| RS1554643584 |
PUF60
|
Health Risk |
Likely pathogenic |
8q24.3 microdeletion syndrome, CHARGE syndrome |
| RS1554643598 |
PUF60
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554643619 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1554643738 |
GLDC
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1554644678 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1554645052 |
RUSC2
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 61 |
| RS1554645551 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554646517 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1554646529 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1554646634 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1554646653 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy 1, Glycine encephalopathy |
| RS1554646710 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1554648060 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1554648113 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1554648117 |
GLDC
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1554648860 |
TG
|
Health Risk |
Pathogenic/Likely pathogenic |
— |